Medical Marijuana, Inc.'s subsidiary Kannaway has won a historic court case in Finland proving the legality of the importation of the company’s cannabidiol (CBD) oil.
“We knew that our operations and sales were legal in Finland, but receiving this ruling from the Finnish High Supreme Administrative Court is promising for the future of our company and the entire industry,” said Kannaway CEO Blake Schroeder.
In 2018, Finnish Customs confiscated a bottle of Kannaway Pure Gold and claimed that it was illegally imported since FIMEA, the Finnish Medicines Agency, lists CBD as a medicinal ingredient, causing the Finnish Customs Authority to take a “blanket approach” in treating all CBD products like medicines. On Friday, October 22, 2021, the Finnish Supreme Administrative Court declared that any product, according to EU directives, would need to be classified as a medicinal product on a case-by-case basis with specific claims on therapeutic effects, dosage, and supporting evidence. In this case, the Supreme Administrative Court has declared that Kannaway Pure Gold hemp oil is not a medicinal product.
“This is a huge win for Kannaway. We hope that this sets an important precedent for other EU jurisdictions where national medicine agencies have held a similar opinion,” said Kannaway Managing Director of International Janne Heimonen. “We have been fighting for many years now to prove that we are not, by law, selling medicine, but that our CBD oil is a nutritional supplement.”